Lisa Elkin

413 total citations
13 papers, 325 citations indexed

About

Lisa Elkin is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Lisa Elkin has authored 13 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 2 papers in Genetics. Recurrent topics in Lisa Elkin's work include Drug Transport and Resistance Mechanisms (4 papers), Cancer Treatment and Pharmacology (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Lisa Elkin is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Cancer Treatment and Pharmacology (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Lisa Elkin collaborates with scholars based in United States, Germany and India. Lisa Elkin's co-authors include Matthew G. Soars, Tatyana Zvyaga, Mary Ellen Cvijic, Yurong Lai, A. David Rodrigues, Brian Kraybill, Kevan M. Shokat, David O. Morgan, Justin D. Blethrow and Paul C. Bridgman and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Lisa Elkin

13 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa Elkin United States	8	158	130	54	43	34	13	325
David M. Cross United Kingdom	10	126 0.8×	182 1.4×	49 0.9×	8 0.2×	28 0.8×	18	385
Kevin M. Huang United States	12	151 1.0×	103 0.8×	19 0.4×	30 0.7×	27 0.8×	28	343
Bryan D. Marks United States	13	83 0.5×	244 1.9×	138 2.6×	17 0.4×	22 0.6×	17	442
William Neway United States	11	203 1.3×	264 2.0×	98 1.8×	121 2.8×	52 1.5×	14	557
Adrian Stecuła United States	10	129 0.8×	163 1.3×	43 0.8×	48 1.1×	12 0.4×	10	407
Joanna Budworth United Kingdom	8	115 0.7×	239 1.8×	26 0.5×	17 0.4×	27 0.8×	8	383
Tiffany Cho Canada	9	178 1.1×	197 1.5×	77 1.4×	13 0.3×	67 2.0×	15	423
Yoshiyuki Tenda Japan	9	308 1.9×	129 1.0×	35 0.6×	208 4.8×	55 1.6×	10	545
Alessio Malacrida Italy	11	66 0.4×	263 2.0×	34 0.6×	7 0.2×	16 0.5×	25	390
Andrea A. Romeo Switzerland	8	53 0.3×	228 1.8×	37 0.7×	7 0.2×	22 0.6×	13	357

Countries citing papers authored by Lisa Elkin

Since Specialization

Citations

This map shows the geographic impact of Lisa Elkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Elkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Elkin more than expected).

Fields of papers citing papers by Lisa Elkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Elkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Elkin. The network helps show where Lisa Elkin may publish in the future.

Co-authorship network of co-authors of Lisa Elkin

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Elkin. A scholar is included among the top collaborators of Lisa Elkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Elkin. Lisa Elkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Elkin, Lisa, et al.. (2017). Challenges and Opportunities in Enabling High-Throughput, Miniaturized High Content Screening. Methods in molecular biology. 1683. 165–191. 8 indexed citations

Markwalder, Jay A., Steven P. Seitz, Yuval Blat, et al.. (2016). Identification and optimization of a novel series of indoleamine 2,3-dioxygenase inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(3). 582–585. 23 indexed citations

Elkin, Lisa, et al.. (2016). Development of a high‐throughput mass spectrometry based analytical method to support an in vitro OATP1B1 inhibition screening assay. Rapid Communications in Mass Spectrometry. 30(15). 1787–1796. 3 indexed citations

Tokarski, John S., Adriana Zupa-Fernandez, Jeffrey Tredup, et al.. (2015). Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain. Journal of Biological Chemistry. 290(17). 11061–11074. 84 indexed citations

Elkin, Lisa, David Harden, S. Adrian Saldanha, et al.. (2015). Just-in-Time Compound Pooling Increases Primary Screening Capacity without Compromising Screening Quality. SLAS DISCOVERY. 20(5). 577–587. 7 indexed citations

Soars, Matthew G., et al.. (2014). Application of anin vitroOAT assay in drug design and optimization of renal clearance. Xenobiotica. 44(7). 657–665. 7 indexed citations

Shou, Wilson Z., et al.. (2014). Development of an LC–MS/MS method for high throughput quantification of metformin uptake in transporter inhibition assays. Journal of Chromatography B. 967. 211–218. 9 indexed citations

Rodrigues, A. David, Yurong Lai, Mary Ellen Cvijic, et al.. (2013). Drug-Induced Perturbations of the Bile Acid Pool, Cholestasis, and Hepatotoxicity: Mechanistic Considerations beyond the Direct Inhibition of the Bile Salt Export Pump. Drug Metabolism and Disposition. 42(4). 566–574. 86 indexed citations

Velleca, Mark, Sunil Sharma, Michael S. Gordon, et al.. (2010). Abstract 17: Preclinical and phase 1 trial results of JI-101, a novel, oral tyrosine kinase inhibitor that selectively targets VEGFR2, EphB4, and PDGFRβ. Cancer Research. 70(8_Supplement). 17–17. 3 indexed citations

10.

Mitchell, Scott A., Peter Blomgren, James W. Darrow, et al.. (2009). Imidazo[1,2-a]pyrazine diaryl ureas: Inhibitors of the receptor tyrosine kinase EphB4. Bioorganic & Medicinal Chemistry Letters. 19(24). 6991–6995. 28 indexed citations

11.

Velleca, Mark, David R. Brittelli, Lisa Elkin, et al.. (2009). Abstract B11: Preclinical and preliminary phase 1 trial results of JI-101: A novel, oral tyrosine kinase inhibitor that selectively targets VEGFR2, EphB4, and PDGFR. Molecular Cancer Therapeutics. 8(12_Supplement). B11–B11. 5 indexed citations

12.

Kraybill, Brian, Lisa Elkin, Justin D. Blethrow, David O. Morgan, & Kevan M. Shokat. (2002). Inhibitor Scaffolds as New Allele Specific Kinase Substrates. Journal of the American Chemical Society. 124(41). 12118–12128. 46 indexed citations

13.

Bridgman, Paul C. & Lisa Elkin. (2000). Axonal myosins. Journal of Neurocytology. 29(11-12). 831–841. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact